These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7726496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
    Mimoz O, Leotard S, Jacolot A, Padoin C, Louchahi K, Petitjean O, Nordmann P.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):885-90. PubMed ID: 10722486
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G, Guan L, Fontana R, Satta G.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outer membrane permeability of Serratia marcescens to meropenem and imipenem.
    Raimondi A, Pessina A, Cocuzza G.
    J Chemother; 1994 Dec; 6(6):363-7. PubMed ID: 7699421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH.
    Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
    [Abstract] [Full Text] [Related]

  • 9. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C, del Carmen Conejo M, Bernabéu-Wittel M, Pascual A, Jiménez-Mejías ME, de Cueto M, Pachón-Ibáñez ME, García I, Pachón J, Martínez-Martínez L.
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem.
    Pragai Z, Nagy E.
    J Antimicrob Chemother; 1998 Dec; 42(6):821-4. PubMed ID: 10052909
    [Abstract] [Full Text] [Related]

  • 12. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY, Livermore DM.
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H, Harabe ET, Sumita Y, Okuda T, Fukasawa M.
    Chemotherapy; 1992 May; 38(4):218-24. PubMed ID: 1473360
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants.
    Marumo K, Nagaki T, Nakamura Y.
    J Antimicrob Chemother; 1996 Jul; 38(1):47-58. PubMed ID: 8858456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA.
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.
    Rasmussen BA, Bush K, Keeney D, Yang Y, Hare R, O'Gara C, Medeiros AA.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2080-6. PubMed ID: 8878585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.